Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Mar;17(3):383–388. doi: 10.1128/aac.17.3.383

Intrarenal distribution of trimethoprim and sulfamethoxazole.

S Trottier, M G Bergeron, C Lessard
PMCID: PMC283795  PMID: 7425603

Abstract

In the present study, rats were given trimethoprim (TMP, 10 mg/kg), sulfamethoxazole (SMZ, 50 mg/kg), or a combination of the respective doses of TMP and SMZ. Thirty-six rats received each of the drugs studied. Six recipients of a compound (or mixture) were evaluated hourly, from 1 to 6 h after intraperitoneal injection of the agent. At each timed interval, serum, urine, cortex, medulla, and papilla were analyzed for drug content. Peak serum values of 1.1 microgram of TMP and 131.1 microgram of active SMZ (nonacetylated sulfonamide) per ml were observed after injection of the combination TMP-SMZ. Although the cortical, medullary, and papillary TMP concentrations were severalfold higher than the respective serum values (P < 0.01), microbiologically active SMZ did not concentrate in the renal parenchyma and was found in lower concentration there than in the serum (P < 0.01). The levels of SMZ in all parts of the kidney of animals which received the mixture SMZ-TMP were lower than those detected in the animals which were given SMZ alone. The average ratio of active SMZ to TMP within the medulla and the papilla was less than 20 to 1 in the first 2 h. The intrarenal distribution of these drugs may have therapeutic implications.

Full text

PDF
383

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach M. C., Gold O., Finland M. Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole. J Infect Dis. 1973 Nov;128(Suppl):584–p. doi: 10.1093/infdis/128.supplement_3.s584. [DOI] [PubMed] [Google Scholar]
  2. Bergan T., Brodwall E. K. Human pharmacokinetics of a sulfamethoxazole-trimethoprim combination. Acta Med Scand. 1972 Dec;192(6):483–492. doi: 10.1111/j.0954-6820.1972.tb04852.x. [DOI] [PubMed] [Google Scholar]
  3. Bergan T., Brodwall E. K. Kidney transport in man of sulfamethoxazole and trimethoprim. Chemotherapy. 1972;17(5):320–333. doi: 10.1159/000220864. [DOI] [PubMed] [Google Scholar]
  4. Bergeron M. G., Trottier S. Influence of single or multiple doses of gentamicin and netilmicin on their cortical, medullary, and papillary distribution. Antimicrob Agents Chemother. 1979 May;15(5):635–641. doi: 10.1128/aac.15.5.635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bushby S. R., Hitchings G. H. Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother. 1968 May;33(1):72–90. doi: 10.1111/j.1476-5381.1968.tb00475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Craig W. A., Kunin C. M. Distribution of trimethoprim-sulfamethoxazole in tissues of rhesus monkeys. J Infect Dis. 1973 Nov;128(Suppl):575–p. doi: 10.1093/infdis/128.supplement_3.s575. [DOI] [PubMed] [Google Scholar]
  7. Fabre J., Blanchard P., Rudhardt M. Pharmacokinetics of ampicillin, cephalothin and doxycycline in various tissues of the rat. Chemotherapy. 1977;23(3):129–141. doi: 10.1159/000221981. [DOI] [PubMed] [Google Scholar]
  8. Gleckman R. A. Trimethoprim-sulfamethoxazole vs ampicillin in chronic urinary tract infections. A double-blind multicenter cooperative controlled study. JAMA. 1975 Aug 4;233(5):427–431. [PubMed] [Google Scholar]
  9. Harding G. K., Ronald A. R. Clinical experiences: genitourinary infections. A. Infections of the urinary tract. Efficacy of trimethoprim-sulfamethoxazole in bacteriuria. J Infect Dis. 1973 Nov;128(Suppl):641–p. [PubMed] [Google Scholar]
  10. Kaplan S. A., Weinfeld R. E., Abruzzo C. W., McFaden K., Jack M. L., Weissman L. Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man. J Infect Dis. 1973 Nov;128(Suppl):547–p. doi: 10.1093/infdis/128.supplement_3.s547. [DOI] [PubMed] [Google Scholar]
  11. Normand M. APL computer program for the analytical and numerical integration of hormonal disappearance data. Can J Physiol Pharmacol. 1972 Aug;50(8):845–852. doi: 10.1139/y72-122. [DOI] [PubMed] [Google Scholar]
  12. Normand M., Fortier C. Numerical versus analytical integration of hormonal disappearance data. Can J Physiol Pharmacol. 1970 May;48(5):274–281. doi: 10.1139/y70-046. [DOI] [PubMed] [Google Scholar]
  13. Rieder J. Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids. Chemotherapy. 1972;17(1):1–21. doi: 10.1159/000220833. [DOI] [PubMed] [Google Scholar]
  14. Schwartz D. E., Rieder J. Pharmacokinetics of sulfamethoxazole plus trimethoprim in man and their distribution in the rat. Chemotherapy. 1970;15(6):337–355. doi: 10.1159/000220701. [DOI] [PubMed] [Google Scholar]
  15. Schwartz D. E., Ziegler W. H. Assay and pharmacokinetics of trimethoprim in man and animals. Postgrad Med J. 1969 Nov;45(Suppl):32–37. [PubMed] [Google Scholar]
  16. Sharpstone P. The renal handling of trimethoprim and sulphamethoxazole in man. Postgrad Med J. 1969 Nov;45(Suppl):38–42. [PubMed] [Google Scholar]
  17. Whelton A., Sapir D. G., Carter G. G., Kramer J., Walker W. G. Intrarenal distribution of penicillin, cephalothin, ampicillin and oxytetracycline during varied states of hydration. J Pharmacol Exp Ther. 1971 Nov;179(2):419–428. [PubMed] [Google Scholar]
  18. Whelton A., Walker W. G. Editorial: Intrarenal antibiotic distribution in health and disease. Kidney Int. 1974 Sep;6(3):131–137. doi: 10.1038/ki.1974.91. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES